Skip to main content

Table 2 Baseline information on patients for whom information was available (6290/6395) cared by GP participants

From: Implementing a guideline for the treatment of type 2 diabetics: results of a Cluster- Randomized Controlled Trial (C-RCT)

Item

 

Active implementation No (%)

Passive dissemination No (%)

Usual care No (%)

Gender

F

971(50)

991(47)

1060(47)

 

M

981(50)

1115(53)

1172(53)

 

total

1952

2106

2232

Age (years)

<50

139 (7)

119 (6)

128 (6)

 

50–70

1089 (56)

1155 (55)

1279 (57)

 

>70

724 (37)

832 (39)

825 (37)

Patient managed by

GP only

801 (41)

936 (44)

1056 (47)

 

GP with specialist

1130 (58)

1133 (54)

1115 (50)

 

Integrated care

21 (1)

37 (2)

61 (3)

Diabetes duration (years)

<5

691 (35)

673 (32)

781 (35)

 

5–10

718 (37)

778 (37)

803 (36)

 

11–20

364 (19)

479 (23)

456 (20)

 

>20

80 (4)

126 (6)

157 (7)

 

Not known

99 (5)

50 (2)

35 (2)

Glycaemic control

Optimal

457 (23)

571 (27)

495 (22)

 

Acceptable

1005 (52)

1111 (53)

1140 (51)

 

Inadequate

331 (17)

362 (17)

374 (17)

 

Not known

159 (8)

62 (3)

223 (10)

Therapy

Diet only

319 (16)

254 (12)

358 (16)

 

Pharmacological

1633 (84)

1852(88)

1874(84)

Hypertension

Yes

1183 (61)

1334 (63)

1334 (60)

 

No

748 (38)

741 (35)

864 (39)

 

Not known

21 (1)

31 (2)

34 (1)

Hypercolesterolemia

Yes

802 (41)

952 (45)

1037 (47)

 

No

1066 (55)

1085 (52)

1099 (49)

 

Not known

84 (4)

69 (3)

96 (4)

Smoking

Yes

336 (17)

416 (20)

400 (18)

 

No

1494 (77)

1597 (76)

1672 (75)

 

Not known

122 (6)

93 (4)

160 (7)

BMI

Normal (<25)

351 (18)

374 (18)

365 (16)

 

Overweight (25–29)

628 (32)

726 (35)

771 (35)

 

Obese (>29)

307 (16)

366 (17)

370 (17)

 

Not known

666(34)

640 (30)

726 (33)